|
|
| 1. |
Advances in targeted therapies II |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 0-0
GUESTEDITORS,
F CBREEDVELD,
J RKALDEN,
J SSMOLEN,
Preview
|
PDF (68KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 2. |
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000) |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 1-2
D EFURST,
F CBREEDVELD,
G RBURMESTER,
J JCROFFORD,
PEMERY,
MFELDMANN,
J RKALDEN,
A FKAVANAUGH,
E CKEYSTONE,
L GKLARESKOG,
P ELIPSKY,
R NMAINI,
A SRUSSELL,
D LSCOTT,
J SSMOLEN,
L B AVAN DE PUTTE,
T LVISHER,
M HWEISMAN,
Preview
|
PDF (89KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 3. |
Post-transcriptional regulation of tumour necrosis factor α production |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 3-5
PaulAnderson,
Preview
|
PDF (120KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 4. |
Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 6-16
Bharat BAggarwal,
Preview
|
PDF (240KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 5. |
Targeting interleukin 18 with interleukin 18 binding protein |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 17-20
Charles ADinarello,
Preview
|
PDF (135KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 6. |
Anti-interleukin 6 receptor antibody treatment in rheumatic disease |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 21-27
NorihiroNishimoto,
TadamitsuKishimoto,
KazuyukiYoshizaki,
Preview
|
PDF (282KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 7. |
Clinical outcome measures in rheumatoid arthritis |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 28-31
Piet L C Mvan Riel,
Anke Mvan Gestel,
Preview
|
PDF (128KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 8. |
Efficacy and toxicity of old and new disease modifying antirheumatic drugs |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 32-35
PeterTugwell,
VivianWelch,
MariaSuarez-Almazor,
BeverleyShea,
GeorgeWells,
Preview
|
PDF (154KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 9. |
Which post-marketing database and studies does EMEA require |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 36-37
GottfriedKreutz,
LengHeng,
Preview
|
PDF (113KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
| 10. |
The role of national agencies in the managed introduction of new drugs for arthritis |
| |
Annals of Rheumatic Diseases,
Volume 59,
Issue suppl_1,
2000,
Page 38-40
KatrinaSimister,
Preview
|
PDF (92KB)
|
|
ISSN:1468-2060
出版商:annrheumdis
年代:2000
数据来源: BMJ
|
|
首页
Volume 59 issue suppl_1